September 22, 2016 Vasectomies not linked to increased prostate cancer risk Having a vasectomy doesn't increase a man's risk of developing prostate cancer or dying from it, a U.S. study suggests.
September 19, 2016 Cancer-risk genetic testing reports can vary from lab to lab Testing for gene mutations linked to cancer risk may guide how a patient is treated, but the determination of whether a mutation is dangerous or benign can vary from lab to lab, according to a recent study.
September 15, 2016 Too soon to tell if 9/11 firefighters face increased cancer risk, study says Fifteen years after the 9/11 attacks, the jury is still out on whether firefighters who worked at the World Trade Center site have increased odds of developing cancer, a U.S. study suggests.
September 15, 2016 Treat or monitor early prostate cancer? 10-year survival is the same, study says Men with early prostate cancer who choose to closely monitor their disease are just as likely to survive at least 10 years as those who have surgery or radiation, finds a major study that directly tested and compared these options.
August 23, 2016 Pfizer boosts cancer drug roster with $14B Medivation deal Pfizer Inc, beating out numerous other bidders, said it would buy U.S. cancer drug company Medivation Inc for $14 billion in cash, adding its blockbuster prostate cancer drug Xtandi to the company's growing oncology roster.
July 26, 2016 American Cancer Society disputes study on rising prostate cancer cases The American Cancer Society is disputing results from a study publicized last week by Northwestern University researchers that suggested a sharp rise in the number of deadly, metastatic prostate cancer cases.
July 19, 2016 Metastatic prostate cancer cases rising, study finds The number of deadly metastatic prostate cancer cases increased considerably in the last decade, potentially due to a recent decrease in the number of men screened for disease, according to a new study.
July 14, 2016 Antipsychotic drug also relieves nausea from cancer chemotherapy Adding the cheap antipsychotic drug olanzapine to conventional anti-vomiting medicine can help prevent nausea in cancer patients, according to a new test of 380 volunteers.
July 12, 2016 Cancer hospital advertising triples since 2005 Between 2005 and 2014, U.S. cancer centers upped their spending on ads targeting the general public, with 890 centers spending $173 million on ads by 2014, according to a new analysis.
July 12, 2016 Bionic butt could lead to better prostate exams Let's face it, the medical standard for diagnosing the second most common cancer in men is rather, well, unrefined: a doctor inserts his or her index finger into the anus and feels around for any hard masses on the prostate gland.